by Igen BioLab Group | Feb 27, 2020 | News
Microbiota have emerged as key modulators of both the carcinogenic process and the immune response against cancer cells, and, thus, it seems to influence the efficacy of immunotherapy. While most studies have focused on analyzing the influence of gut microbiota, its...
by Igen BioLab Group | Feb 18, 2020 | News
Micro-organisms in the gut support healthy digestion by helping nerve cells within the intestine to regulate the contraction and relaxation of the muscle wall of the colon, according to new research from the Crick and Bern University. The study, published in Nature,...
by Igen BioLab Group | Jan 14, 2020 | News
More than a decade after the launch of the Human Microbiome Project, research in this field has grown exponentially, with studies associating microbial states or species with disorders including novel infectious etiologies and complex human disease. Scientists are...
by Igen BioLab Group | Dec 20, 2019 | News
Implications for pathogenesis, diagnosis, and therapy Colorectal cancer (CRC) is one of the most frequently diagnosed cancers and leading cause of cancer-related deaths worldwide. In recent years, there has been a growing realization that lifestyle plays a major role...
by Igen BioLab Group | Oct 14, 2019 | News
Bacterial dysbiosis accompanies carcinogenesis in malignancies such as colon and liver cancer, and has recently been implicated in the pathogenesis of pancreatic ductal adenocarcinoma (PDA)1. However, the mycobiome has not been clearly implicated in tumorigenesis....
